Companies / Isomab
Isomab
Company
Isomab is developing a first-in-class antibody therapeutic that restores the heart's own collateral circulation
Isomab has 4 investors on file, among them Broadview Ventures, Mercia Ventures and Nottingham Technology Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Investor | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Isomab and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Broadview Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/isomab.bio/investors
# also
GET /v1/companies/isomab.bio
GET /v1/companies/isomab.bio/news